Multicentric Randomized Phase III Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus 5-fluorouracil, Leucovorin, Irinotecan and Oxaliplatin (mFolfirinox) in Patients With Resected Pancreatic Adenocarcinoma
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 01 Jul 2018
At a glance
- Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; Gemcitabine (Primary) ; Irinotecan (Primary) ; Oxaliplatin (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Acronyms PRODIGE 24/CCTG PA.6
- Sponsors UNICANCER
- 01 Jul 2018 Results presented in the Debiopharm Group media release.
- 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology
- 24 Jan 2017 Planned End Date changed from 1 Jan 2020 to 1 Sep 2021.